GSK Plc (GSK)
48.13
+0.01
(+0.02%)
USD |
NYSE |
Sep 11, 16:00
48.12
-0.01
(-0.02%)
After-Hours: 20:00
GSK Price : 48.13 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 48.70 | 48.80 | 47.85 | 48.13 | 2.277M |
| Sep 10, 2026 | 48.47 | 48.59 | 47.98 | 48.12 | 2.151M |
| Sep 09, 2026 | 48.82 | 49.16 | 48.60 | 48.63 | 2.405M |
| Sep 08, 2026 | 49.00 | 49.23 | 48.54 | 48.54 | 3.062M |
| Sep 04, 2026 | 49.70 | 50.06 | 49.66 | 49.89 | 2.287M |
| Sep 03, 2026 | 51.50 | 51.52 | 50.19 | 50.87 | 2.443M |
| Sep 02, 2026 | 50.36 | 51.08 | 50.04 | 50.44 | 2.938M |
| Sep 01, 2026 | 51.11 | 51.26 | 50.46 | 50.66 | 3.272M |
| Aug 31, 2026 | 50.62 | 50.82 | 50.25 | 50.25 | 2.394M |
| Aug 28, 2026 | 50.22 | 50.88 | 49.95 | 50.82 | 3.432M |
| Aug 27, 2026 | 50.94 | 51.03 | 50.16 | 50.27 | 2.466M |
| Aug 26, 2026 | 51.90 | 52.09 | 51.40 | 51.43 | 1.717M |
| Aug 25, 2026 | 51.57 | 52.21 | 51.51 | 52.07 | 2.699M |
| Aug 24, 2026 | 51.54 | 51.95 | 51.40 | 51.78 | 2.886M |
| Aug 21, 2026 | 51.35 | 52.57 | 51.35 | 52.41 | 2.405M |
| Aug 20, 2026 | 52.57 | 52.63 | 51.86 | 51.96 | 3.598M |
| Aug 19, 2026 | 51.40 | 52.94 | 51.35 | 52.88 | 3.902M |
| Aug 18, 2026 | 50.76 | 51.35 | 50.65 | 51.15 | 2.829M |
| Aug 17, 2026 | 49.93 | 50.36 | 49.88 | 50.28 | 2.815M |
| Aug 14, 2026 | 49.04 | 49.57 | 48.86 | 49.52 | 3.723M |
| Aug 13, 2026 | 50.56 | 50.63 | 50.18 | 50.45 | 2.693M |
| Aug 12, 2026 | 50.11 | 50.47 | 49.86 | 50.30 | 4.093M |
| Aug 11, 2026 | 51.95 | 52.36 | 50.90 | 50.90 | 2.925M |
| Aug 10, 2026 | 51.53 | 52.20 | 51.47 | 52.16 | 3.136M |
| Aug 07, 2026 | 52.71 | 53.08 | 52.42 | 52.96 | 2.522M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 160.17 |
| Eli Lilly & Co. | 1115.70 |
| Merck & Co., Inc. | 143.93 |
| Novo Nordisk A/S | 43.07 |
| Novartis AG | 137.16 |
Price Related Metrics
| PE Ratio | 15.16 |
| PS Ratio | 2.204 |
| PEG Ratio | 0.3162 |
| Price to Book Value | 4.157 |
| Price to Free Cash Flow | 14.83 |
| Earnings Yield | 6.59% |
| Market Cap | 97.35B |
| PEGY Ratio | 0.293 |
| Operating PE Ratio | 8.817 |
| Normalized PE Ratio | 10.44 |